Literature DB >> 2417762

Serodiagnosis of toxoplasma infection using a purified parasite protein (P30).

F Santoro, D Afchain, R Pierce, J Y Cesbron, G Ovlaque, A Capron.   

Abstract

The major surface protein (P30) of Toxoplasma gondii has been purified by immunoabsorption with anti-P30 monoclonal antibodies linked to a glutardialdehyde activated affinity absorbant. SDS-PAGE analysis of the eluted material followed by silver staining showed only a single band of 30,000 mol wt. Western blotting using antibodies from a rabbit immunized with purified P30 against the total Toxoplasma extract separated by SDS-PAGE again revealed an unique antigen of 30,000 daltons. The presence of repeated epitopes within P30 was confirmed by a two-site/one-antibody radiometric assay with the purified protein. Sandwich ELISA procedures with purified P30 clearly demonstrated that all 37 tested patients with acute toxoplasmosis presented significantly high levels of IgM anti-P30 antibodies. In addition, all 40 tested patients with chronic toxoplasma infection also showed high IgG anti-P30 antibody levels. These findings represent an essential step for the development of new reagents for the diagnosis of toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417762      PMCID: PMC1577441     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  A microplate enzyme-immunoassay for toxoplasma antibody.

Authors:  A Voller; D E Bidwell; A Bartlett; D G Fleck; M Perkins; B Oladehin
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

2.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.

Authors:  C Rodriguez; D Afchain; A Capron; C Dissous; F Santoro
Journal:  Eur J Immunol       Date:  1985-07       Impact factor: 5.532

5.  Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody.

Authors:  L H Kasper; J H Crabb; E R Pfefferkorn
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

6.  Schistosoma mansoni surface antigen defined by a rat monoclonal IgG2a.

Authors:  C Dissous; J M Grzych; A Capron
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

7.  Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis.

Authors:  A M Johnson; P J McDonald; S H Neoh
Journal:  J Protozool       Date:  1983-05

8.  Partially purified antigen preparations of Toxoplasma gondii protect against lethal infection in mice.

Authors:  F G Araujo; J S Remington
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein.

Authors:  G N Godson; J Ellis; P Svec; D H Schlesinger; V Nussenzweig
Journal:  Nature       Date:  1983 Sep 1-7       Impact factor: 49.962

10.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

View more
  29 in total

1.  Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii.

Authors:  A Makioka; A Kobayashi
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

2.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Bicentric evaluation of Access Toxo immunoglobulin M (IgM) and IgG assays and IMx toxo IgM and IgG assays and comparison with Platelia Toxo IgM and IgG assays.

Authors:  A Decoster; B Lecolier
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

4.  Advantage of using 35,000-molecular-weight protein for testing of Toxoplasma gondii immunoglobulin M.

Authors:  P Deletoille; G Ovlaque; B Slizewicz
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

5.  Performance characteristics of current-generation Immulite 2000 TORCH Assays.

Authors:  A R Centonze; E Tonolli; R Fontana
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

6.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

7.  Analysis by immunoblotting of Toxoplasma gondii exo-antigens and comparison with somatic antigens.

Authors:  M H Bessières; S Le Breton; J P Séguéla
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

8.  Toxoplasma antigens recognized by naturally occurring human antibodies.

Authors:  I Potasman; F G Araujo; J S Remington
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

9.  Detection of anti-toxoplasma immunoglobulin A antibodies by Platelia-Toxo IgA directed against P30 and by IMx Toxo IgA for diagnosis of acquired and congenital toxoplasmosis.

Authors:  A Decoster; P Gontier; E Dehecq; J L Demory; M Duhamel
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies.

Authors:  A Decoster; B Slizewicz; J Simon; C Bazin; F Darcy; G Vittu; C Boulanger; Y Champeau; J L Demory; M Duhamel
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.